450960
氯化镥(III)
anhydrous, powder, 99.99% trace metals basis
别名:
三氯化镥, 氯化镥
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
线性分子式:
LuCl3
化学文摘社编号:
分子量:
281.33
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12352302
EC Number:
233-240-1
MDL number:
Assay:
99.99% trace metals basis
Grade:
anhydrous
Form:
powder
grade
anhydrous
assay
99.99% trace metals basis
form
powder
reaction suitability
core: lutetium, reagent type: catalyst
impurities
≤150.0 ppm Trace Rare Earth Analysis
mp
905 °C (lit.)
density
3.98 g/mL at 25 °C (lit.)
SMILES string
Cl[Lu](Cl)Cl
InChI
1S/3ClH.Lu/h3*1H;/q;;;+3/p-3
InChI key
AEDROEGYZIARPU-UHFFFAOYSA-K
Application
氯化镥用途：
- 作为前体合成不对称氢胺化反应的手性桥联镥催化剂。
- 作为起始原料制备氧化镥基纳米荧光材料。
- 制作闪烁探测器，如镥铝石榴石(LuAG)。
存储类别
11 - Combustible Solids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
商品
Rare earth elements are vital in everyday life worldwide: catalysts in cars, colors in screens, magnets in electronics. Essential for modern living.
Development of new technologies for the manufacturing of nanocrystalline scintillation materials
Nikoloz V Jalabadze, et al.
IEEE transactions on nuclear science, 55, 1514-1522 (2008)
A Chiral-Bridged Aminotroponiminate Complex of Lutetium as Catalyst for the Asymmetric Hydroamination
Nils Meyer, et al.
Organometallics, 25, 4179-4182 (2006)
Swayamjeet Satapathy et al.
Nuclear medicine communications, 41(7), 629-635 (2020-05-07)
Peptide receptor radionuclide therapy (PRRT) has been shown to be useful in inoperable/metastatic medullary thyroid carcinoma (MTC). However, the role of concomitant PRRT and low-dose capecitabine therapy has not yet been studied in these patients. This study was conducted to
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 450960-5G | 04061838140135 |
| 450960-1G | 04061838140128 |